5.PERSONAL SPACE PERCEPTION IN HUMAN ELBOW JOINT
JUNKO MIYAZAKI ; HIROSHI KURATA ; YOSHINORI OGAWA ; YOSHIHIRO SAITO ; ATSUSHI TOKIOKA ; KUNIHIKO HARADA ; SOTOYUKI USUI ; MAKOTO MASUDA
Japanese Journal of Physical Fitness and Sports Medicine 1982;31(4):242-250
In order to examine the personal space perception, measurements were conducted on both elbows in 14 men and 46 women. Each subject, with his (or her) eyes closed and with his upper arm fixed horizontally, was instructed to stop the vertical and horizontal swing motion of his lower arm at the point he considered to be the middle of the range of possible motion on the front and side of plane at his shoulder, and this was repeated ten times. In various conditions, similar measurements were also done to study factors affecting the personal space perception in 14 men.
Mean values of bisected angles in percentage against range of motion were deviated from the middle points in the direction of the elbow extension, although there were large differences between the individuals. The deviation was smallest in the vertical. side of plane, and was larger in the horizontal plane than that in the vertical plane. The deviation was not so much affected by the various conditions.
It was suggested that the gain of the personal space perception is higher in the elbow extension than in the elbow flexion and its difference is larger in the horizontal plane than in vertical plane of the human elbow joint.
6.A Case in which Botulinum Toxin was Effective for Palliative Care of Multiple System Atrophy
Daiki Kikuchi ; Hironobu Itou ; Yoshihiro Ogawa ; Satomi Kasai ; Ken Kikuchi ; Kiyoshi Sawauchi ; Naoko Yamada ; Setsuko Nakamura ; Izumi Yamato
An Official Journal of the Japan Primary Care Association 2016;39(3):163-165
7.9-4 Education Given at Jichi Medical University's Dormitory during the COVID-19 Pandemic: Strategies and Challenges in a Boarding Medical College
Yosikazu NAKAMURA ; Yoshihiro ITAI ; Nobuko MAKINO ; Masaaki SATO ; Shigeo NAGASHIMA ; Yukiko ISHIKAWA ; Kenji KUROIWA ; Teppei SASAHARA ; Yasuko NODA ; Masami MATSUMURA ; Shizukiyo ISHIKAWA ; Masanori OGAWA ; Akinori YAMABE ; Yoshikazu ASADA
Medical Education 2020;51(3):306-307
8.The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center
Akihisa OHNO ; Nao FUJIMORI ; Toyoma KAKU ; Masayuki HIJIOKA ; Ken KAWABE ; Naohiko HARADA ; Makoto NAKAMUTA ; Takamasa OONO ; Yoshihiro OGAWA
Clinical Endoscopy 2022;55(6):784-792
Background/Aims:
Patients with acute cholecystitis (AC) after metallic stent (MS) placement for malignant biliary obstruction (MBO) have a high surgical risk. We performed percutaneous transhepatic gallbladder aspiration (PTGBA) as the first treatment for AC. We aimed to identify the risk factors for AC after MS placement and the poor response factors of PTGBA.
Methods:
We enrolled 401 patients who underwent MS placement for MBO between April 2011 and March 2020. The incidence of AC was 10.7%. Of these 43 patients, 37 underwent PTGBA as the first treatment. The patients’ responses to PTGBA were divided into good and poor response groups.
Results:
There were 20 patients in good response group and 17 patients in poor response group. Risk factors for cholecystitis after MS placement included cystic duct obstruction (p<0.001) and covered MS (p<0.001). Cystic duct obstruction (p=0.003) and uncovered MS (p=0.011) demonstrated significantly poor responses to PTGBA. Cystic duct obstruction is a risk factor for cholecystitis and poor response factor for PTGBA, whereas covered MS is a risk factor for cholecystitis and an uncovered MS is a poor response factor of PTGBA for cholecystitis.
Conclusions
The onset and poor response factors of AC after MS placement were different between covered and uncovered MS. PTGBA can be a viable option for AC after MS placement, especially in patients with covered MS.
9.Potential Applicability of Local Resection With Prophylactic Left Gastric Artery Basin Dissection for Early-Stage Gastric Cancer in the Upper Third of the Stomach
Yoshimasa AKASHI ; Koichi OGAWA ; Katsuji HISAKURA ; Tsuyoshi ENOMOTO ; Yusuke OHARA ; Yohei OWADA ; Shinji HASHIMOTO ; Kazuhiro TAKAHASHI ; Osamu SHIMOMURA ; Manami DOI ; Yoshihiro MIYAZAKI ; Kinji FURUYA ; Shoko MOUE ; Tatsuya ODA
Journal of Gastric Cancer 2022;22(3):184-196
Purpose:
Total or proximal gastrectomy of the upper-third early gastric cancer (u-EGC) often causes severe post-gastrectomy syndrome, suggesting that these procedures are extremely invasive for patients without pathologically positive lymph node (LN) metastasis. This study aimed to evaluate the clinical applicability of a stomach function-preserving surgery, local resection (LR), with prophylactic left gastric artery (LGA)-basin dissection (LGA-BD).
Materials and Methods:
The data of patients with u-EGC (pathologically diagnosed as T1) were retrospectively analyzed. Total gastrectomy was performed in 30 patients, proximal gastrectomy in 45, and subtotal gastrectomy in 6; the LN status was evaluated assuming that the patients had already underwent LR + LGA-BD. This procedure was considered feasible in patients without LN metastases or in patients with cancer in the LGA basin. The reproducibility of the results was also evaluated using an external validation dataset.
Results:
Of the 82 eligible patients, 79 (96.3%) were cured after undergoing LR + LGA-BD, 74 (90.2%) were pathologically negative for LN metastases, and 5 (6.1%) had LN metastases, but these findings were only observed in the LGA basin. Similarly, of the 406 eligible tumors in the validation dataset, 396 (97.5%) were potentially curative. Tumors in the lesser curvature, post-endoscopic resection status, and small tumors (<20 mm) were considered to be stronger indicators of LR + LGA-BD as all subpopulation cases met our feasibility criteria.
Conclusions
More than 95% of the patients with u-EGC might be eligible for LR + LGA-BD.This function-preserving procedure may contribute to the development of u-EGC without pathological LN metastases, especially for tumors located at the lesser curvature.
10.Onigiri Esophagography as a Screening Test for Esophageal Motility Disorders
Shohei HAMADA ; Eikichi IHARA ; Kazumasa MUTA ; Masafumi WADA ; Yoshitaka HATA ; Hiroko IKEDA ; Yoshimasa TANAKA ; Haruei OGINO ; Takatoshi CHINEN ; Yoshihiro OGAWA
Journal of Neurogastroenterology and Motility 2022;28(1):43-52
Background/Aims:
No screening test for esophageal motility disorder (EMD) has been established, the objective of this study is to examine the potential usefulness of our newly developed “Onigiri esophagography” combined with an obstruction level (OL) classification system in screening for EMD.
Methods:
A total of 102 patients with suspected EMDs who underwent both high-resolution manometry (HRM) and Onigiri esophagography between April 2017 and January 2019 were examined. The EMD diagnosis was performed based on the Chicago classification version 3.0 by HRM. Onigiri esophagography was performed using a liquid medium (barium sulfate) followed by a solid medium, which consisted of an Onigiri (a Japanese rice ball) with barium powder. The extent of medium obstruction was assessed by the OL classification, which was defined in a stepwise fashion from OL0 (no obstruction) to OL4 (severe obstruction).
Results:
The patients with OL0 (32.3%), OL1 (50.0%), OL2 (88.0%), OL3 (100.0%), and OL4 (100.0%) were diagnosed EMDs by HRM. The area under the curve, as determined by a receiver operating characteristic analysis, for the OL classification was 0.86. Using the cutoff value of OL1, the sensitivity and specificity were 87.3% and 61.3%, respectively, while using a cutoff value of OL2, the sensitivity and specificity were 73.2% and 90.3%, respectively.
Conclusion
In conclusion, Onigiri esophagography combined with the OL classification system can be used as a screening test for EMDs with a cutoff value of OL1.